This page lists the paediatric cardiology hospitals in our directory offering Ventricular Septal Defect (VSD) Repair in Hyderabad, India, including KIMS Hospitals, Secunderabad, Yashoda Hospitals, Secunderabad, Apollo Hospital DRDO, Apollo Hospitals, Jubilee Hills. Each listing links through to the hospital's full profile page.
Ask us about ventricular septal defect (vsd) repair in Hyderabad, India
Share a few details and our care coordination team will get back to you with next steps.
Compare 4 accredited hospitals for Paediatric Cardiology in Hyderabad, India
Featured🇮🇳 KIMS Hospitals, Secunderabad
Ranks #1 in this list by listed rating (4.8/5 from 743 reviews).
🇮🇳 Yashoda Hospitals, Secunderabad
Ranks #2 in this list by listed rating (4.7/5 from 518 reviews).
🇮🇳 Apollo Hospital DRDO
Ranks #3 in this list by listed rating (4.5/5 from 82 reviews).
🇮🇳 Apollo Hospitals, Jubilee Hills
Ranks #4 in this list by listed rating (4.1/5 from 44 reviews).
How we selected these hospitals
A hospital appears on this page when Paediatric Cardiology is among its listed specialties and it is located in Hyderabad, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for Ventricular Septal Defect (VSD) Repair in Hyderabad, India?
Choosing the right hospital for ventricular septal defect (vsd) repair is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include paediatric cardiology rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding Ventricular Septal Defect (VSD) Repair
Ventricular Septal Defect (VSD) Repair is a well-established cardiac surgical procedure that closes abnormal openings in the interventricular septum, restoring normal hemodynamic function and preventing long-term complications such as pulmonary hypertension and Eisenmenger syndrome. Surgical and catheter-based closure techniques carry a success rate exceeding 95% in experienced pediatric cardiac centers, with most patients achieving full, active lives post-repair. GAF Healthcare connects international families with JCI- and NABH-accredited hospitals in India and JCI- and DHA-accredited centers in the UAE, offering world-class pediatric cardiology care at a fraction of Western costs, backed by end-to-end patient coordination. Hospital Stay: 7–12 days (including 2–4 days in the Pediatric Cardiac ICU followed by step-down ward care) • Total Stay in Country (Fit-to-Fly): 4–6 weeks post-surgery (international long-haul flight clearance typically granted after complete sternal healing and stable hemodynamics, confirmed by the treating cardiologist) • Success Rate: 95–98%
Clinical Overview
A Ventricular Septal Defect is a congenital cardiac anomaly defined by one or more openings in the muscular or membranous partition separating the left and right ventricles. Classified by location — perimembranous (most common, ~80% of cases), muscular, inlet, and outlet (supracristal) — VSDs create a left-to-right intracardiac shunt driven by the physiologically higher left ventricular pressure. This shunt results in pulmonary overcirculation, obliging the right ventricle and pulmonary vasculature to handle excess volume, progressively increasing the risk of right ventricular hypertrophy, pulmonary arterial hypertension (PAH), and — if left untreated beyond the critical window — irreversible Eisenmenger physiology, wherein the shunt reverses to right-to-left and the patient becomes inoperable. The hemodynamic severity of a VSD is quantified by the Qp:Qs ratio (pulmonary-to-systemic blood flow ratio) derived from echocardiography or cardiac catheterization. A Qp:Qs ≥ 2:1, or any VSD associated with symptomatic heart failure, failure to thrive, recurrent lower respiratory tract infections, or aortic valve prolapse, constitutes a firm indication for intervention. Pulmonary vascular resistance (PVR) calculation using the Wood Units index, as well as vasoreactivity testing with inhaled nitric oxide, is essential before surgery in patients with established PAH to assess operability. The Ross Heart Failure Score for infants and the NYHA functional classification for older children and adults guide urgency stratification. The current standard of care for hemodynamically significant VSDs involves either open surgical repair under cardiopulmonary bypass (CPB) or, when anatomy permits, transcatheter device closure. Surgical repair via median sternotomy with patch closure using autologous pericardium or synthetic Dacron/Gore-Tex patches remains the gold standard, offering definitive single-stage correction with excellent long-term durability. Transcatheter closure using devices such as the Amplatzer Septal Occluder, Amplatzer Muscular VSD Occluder, or the newer Lifetech CeraFlex device has expanded non-surgical options for muscular and select perimembranous VSDs in appropriate anatomical candidates. Hybrid approaches — combining surgical and catheterization techniques in a single session — are employed in complex or multiple-defect scenarios at high-volume centers.
Who is a Candidate?
• Eligibility — Surgical Repair (Open): • Perimembranous or outlet VSDs of any size associated with hemodynamic compromise (Qp:Qs ≥ 2:1) • Any VSD with associated aortic valve prolapse or regurgitation, regardless of shunt size • VSDs causing symptomatic congestive heart failure (CHF), failure to thrive, or recurrent pulmonary infections refractory to medical management • Infants with large unrestrictive VSDs and weight ≥ 3.5 kg (lower weight may require initial pulmonary artery banding as a bridge) • Adults with previously unrepaired VSDs with preserved pulmonary vascular reactivity (PVR < 8 Wood Units or reversible on vasodilator testing) • Eligibility — Transcatheter Device Closure: • Muscular VSDs with favorable rim anatomy (≥ 4 mm from aortic and tricuspid valves, ≥ 4 mm rims) • Perimembranous VSDs in select anatomical configurations (assessed by 3D transesophageal echocardiography) • Residual or recurrent VSDs post-surgical repair • Weight typically ≥ 5 kg for catheter-based access (though smaller patients may qualify at expert centers) • Required Diagnostic Workup: • Transthoracic Echocardiography (TTE) — first-line imaging; Doppler assessment of shunt direction, velocity, estimated right ventricular systolic pressure (RVSP), and defect morphology • Transesophageal Echocardiography (TEE) or 3D TEE — precise anatomical delineation for surgical/device planning and intraoperative guidance • Cardiac MRI (CMR) — quantification of Qp:Qs, ventricular volumes, and myocardial function, particularly in complex anatomy • Cardiac Catheterization with hemodynamic study — mandatory when PAH is suspected; includes PVR calculation and nitric oxide vasoreactivity testing • Chest X-ray — cardiomegaly, pulmonary plethora assessment • 12-lead ECG — right ventricular hypertrophy patterns, conduction abnormalities • Full Blood Count, Coagulation Profile, Renal and Hepatic Function Tests, Blood Group & Crossmatch • Genetic and chromosomal testing (e.g., array-CGH, FISH for 22q11.2 deletion) when syndromic associations (Down syndrome, DiGeorge syndrome) are suspected • Absolute Contraindications: • Established Eisenmenger syndrome (irreversible PAH with PVR > 8 Wood Units, non-reactive to vasodilators, resting oxygen saturation < 90% on room air with right-to-left shunting) • Active systemic infection or sepsis (procedure must be deferred until resolution) • Severe uncorrected coagulopathy unresponsive to medical management • Unfavorable VSD anatomy for device closure (inadequate rims, proximity to conduction system) — routes patient toward surgical repair rather than absolute contraindication to any intervention
Treatment Options & Approaches
1. OPEN SURGICAL REPAIR (Gold Standard) Performed under general anesthesia via median sternotomy, with the patient placed on cardiopulmonary bypass (CPB) using a membrane oxygenator. Myocardial protection is achieved through antegrade cold blood cardioplegia (del Nido cardioplegia is widely favored in pediatric centers for its single-dose, prolonged arrest duration). The defect is approached through a right atriotomy (transatrial approach — the preferred technique, preserving right ventricular function), or occasionally through the right ventricle (transventricular) or pulmonary artery (transpulmonary) for outlet VSDs. Closure is accomplished with a patch — autologous glutaraldehyde-fixed pericardium or knitted Dacron — secured with interrupted or continuous pledgeted polypropylene sutures, with meticulous care to avoid the atrioventricular node (Koch's triangle), the bundle of His, and its left and right bundle branches, which course along the inferior margin of perimembranous defects. Intraoperative TEE confirms complete closure and excludes residual shunts or valve compromise before CPB weaning. Total CPB time averages 60–90 minutes; aortic cross-clamp time 30–60 minutes. 2. MINIMALLY INVASIVE SURGICAL REPAIR Right lateral mini-thoracotomy (3–5 cm incision) with peripheral CPB cannulation (femoral or axillary vessels in adults; internal jugular + femoral in pediatric patients) provides excellent cosmetic outcomes and reduced sternal morbidity. Robotic-assisted VSD repair using the da Vinci Surgical System is offered at select high-volume centers in India (e.g., Sri Sathya Sai Institute, Apollo Hospitals Hyderabad) for anatomically suitable adult or adolescent patients, enabling 3D magnified visualization and precise suture placement through sub-centimeter ports. Port-access endoscopic repair is an intermediate option between sternotomy and full robotics. 3. TRANSCATHETER DEVICE CLOSURE Performed under general anesthesia or deep sedation with continuous TEE and fluoroscopic guidance in a hybrid catheterization laboratory. Femoral venous access is obtained; a long sheath is advanced across the defect via a transseptal or direct trans-VSD approach. Device selection is anatomy-dependent: • Amplatzer Muscular VSD Occluder (Abbott): self-centering nitinol mesh with polyester fabric; first-line for muscular VSDs • Amplatzer Membranous VSD Occluder / Piccolo device: for perimembranous VSDs with eccentric disc design to avoid AV nodal injury • Lifetech CeraFlex / CeraTM Occlutech devices: ceramic-surface nitinol devices with reduced nickel ion leakage and lower thrombogenicity Post-deployment, device position is confirmed with both fluoroscopy and TEE before release. The procedure eliminates CPB, sternal incision, and associated morbidity, with discharge typically within 48–72 hours. 4. HYBRID (PERVENTRICULAR) APPROACH Employed for complex muscular VSDs, multiple 'Swiss-cheese' defects, or in critically ill infants where CPB poses prohibitive risk. The cardiac surgeon exposes the right ventricle through a limited sternotomy; a needle is introduced directly through the right ventricular free wall under TEE guidance, and a muscular VSD occluder is deployed without CPB. This approach is also used in neonates with very low birth weight as a bridge or definitive therapy. 5. PULMONARY ARTERY BANDING (PAB) — Palliative Interim Measure In premature neonates (< 2 kg) or infants with multiple comorbidities making primary repair high-risk, surgical banding of the main pulmonary artery reduces excessive pulmonary blood flow and prevents progressive PAH, deferring definitive repair until the patient is an optimal candidate. PAB is not curative and requires a second-stage surgical takedown with VSD closure. 6. MEDICAL MANAGEMENT (Adjunct — Not Definitive) Anti-congestive therapy with loop diuretics (furosemide), aldosterone antagonists (spironolactone), and ACE inhibitors (captopril/enalapril) is used to optimize the patient's condition pre-operatively and in small restrictive VSDs anticipated to close spontaneously. Up to 50–75% of small muscular VSDs and 30% of small perimembranous VSDs close spontaneously by age 2–4 years; these patients are monitored with serial echocardiography.
Recovery
PHASE 1 — PRE-ARRIVAL & REMOTE CONSULTATION (2–4 Weeks Before Travel) • Patient/family submits medical records (echocardiogram reports, cardiac catheterization data, prior surgical notes, growth charts) to GAF Healthcare's medical team • Remote multidisciplinary review by a pediatric cardiac surgeon, pediatric cardiologist, and cardiac anesthesiologist at the chosen center • Provisional surgical or interventional plan communicated in writing, including procedure type, estimated cost, and risk stratification • Medical visa application initiated for India (e-Medical Visa + attendant e-Medical Visa); UAE entry formalities confirmed • Pre-travel checklist provided: current medications, weight/height (critical for pediatric dosing and device sizing), recent blood work PHASE 2 — ARRIVAL & IN-HOSPITAL PRE-OPERATIVE ASSESSMENT (Days 1–3) • Airport pickup arranged by GAF Healthcare; transfer to hospital or affiliated accommodation • Comprehensive inpatient workup: TTE, TEE (if not recently performed), cardiac MRI or catheterization as indicated, complete blood panel, coagulation screen, cross-match, anesthesia assessment, pediatric cardiology ward rounds • Nutritional optimization: if the patient is a malnourished infant, enteral feeding supplementation may be initiated for 48–72 hours pre-operatively • Informed consent process with family conducted in their preferred language via GAF's medical interpreter • Anesthesia briefing; premedication plan finalized PHASE 3 — THE PROCEDURE (Day 3 or 4) • Open Surgical Repair: 3–5 hours total operative time (incision to closure), including CPB weaning and intraoperative TEE confirmation • Transcatheter Closure: 1–2 hours in the catheterization laboratory; no general anesthesia scar; same-day or next-day discharge protocol • Hybrid Repair: 2–3 hours in a combined OR/cath lab environment • Immediate post-procedure transfer to the Pediatric Cardiac Intensive Care Unit (PCICU) PHASE 4 — PCICU STAY (Days 4–7 for surgical; Days 4–5 for transcatheter) • Mechanical ventilation: typically extubated within 4–8 hours post-open repair using fast-track cardiac anesthesia protocols (high-dose opioid-free or opioid-sparing regimens with dexmedetomidine) • Continuous hemodynamic monitoring: arterial line, central venous pressure, near-infrared spectroscopy (NIRS) cerebral oximetry • Vasoactive support (milrinone ± dopamine) weaned as cardiac output improves • Chest drain output monitored; drains removed when output < 3 mL/kg/hour for 4 consecutive hours • Pain management: multimodal — regional nerve blocks, paracetamol, low-dose NSAIDs as renal function permits • First post-operative echocardiogram performed before PCICU discharge to confirm patch integrity PHASE 5 — STEP-DOWN WARD (Days 7–12) • Transition to oral cardiac medications: diuretics tapered over 4–6 weeks, aspirin (post-device closure: 3–6 months antiplatelet therapy) • Sternal precautions taught to caregivers (no lifting under the arms for 6–8 weeks post-sternotomy) • Physiotherapy: deep breathing exercises, graduated mobility • Wound care education; suture/staple removal if non-absorbable • Repeat ECG and chest X-ray; echocardiogram on day 5–7 post-op • Discharge planning: written summary, medications list, emergency contacts, outpatient cardiology follow-up schedule PHASE 6 — POST-DISCHARGE, LOCAL RECOVERY (Weeks 2–6) • Patient stays in GAF Healthcare-arranged accommodation near the hospital • Outpatient cardiology review at 2-week post-discharge mark: clinical examination, echocardiogram, wound check • Fit-to-fly clearance granted when: wound fully healed, no pleural or pericardial effusion on echo, stable rhythm on ECG, no oxygen requirement, and the treating cardiac surgeon formally documents approval • For surgical patients: clearance typically at 4–6 weeks post-operatively • For transcatheter patients: clearance typically at 2–3 weeks post-procedure • Infective endocarditis (IE) prophylaxis: antibiotics recommended for 6 months post-device/patch implant for all dental, respiratory, and invasive procedures (per AHA/ESC guidelines) PHASE 7 — HOME COUNTRY FOLLOW-UP • GAF Healthcare coordinates transfer of a complete digital medical record package (operative notes, echocardiography images/reports, discharge summary, device/implant card) to the patient's home cardiologist • Remote teleconsultation at 3 months, 6 months, and 12 months with the treating team facilitated by GAF Healthcare's telemedicine platform • Annual echocardiographic surveillance recommended for 5 years post-repair
Risks to be aware of
VSD Repair, whether surgical or catheter-based, is a mature procedure with low overall mortality and complication rates at high-volume centers; however, patients and families must be counseled on the following procedure-specific risks with clinical transparency: Surgical Repair Risks: Complete heart block (CHB) is the most feared major complication, occurring in 1–3% of perimembranous VSD repairs due to inadvertent injury to the atrioventricular node or bundle of His; it requires permanent pacemaker implantation. Residual VSD (patch dehiscence or missed small defects) occurs in 3–5% of cases and may require re-intervention. Tricuspid valve regurgitation can develop from leaflet tethering during suture placement. Post-pericardiotomy syndrome — an autoimmune inflammatory response presenting with fever, chest pain, and pericardial effusion — affects 10–15% of pediatric open cardiac surgery patients and responds to NSAIDs or colchicine. Wound infection and mediastinitis are rare (< 1%) but serious complications requiring prolonged antibiotic therapy or surgical debridement. Low cardiac output syndrome in the immediate postoperative period is managed with vasoactive agents. Neurological events (stroke, seizure) related to CPB micro-emboli occur in < 1% at experienced centers using arterial filtration and strict CPB management protocols. Chylothorax, phrenic nerve palsy, and junctional ectopic tachycardia (JET) — the most common postoperative arrhythmia in neonatal/infant cardiac surgery — are recognized but manageable complications. Transcatheter Closure Risks: Device embolization (< 1%) requires urgent surgical or catheter retrieval. Complete heart block is an important concern for perimembranous VSD device closure, with rates reported between 1–5% depending on device type and operator experience. Aortic regurgitation from device interference with the non-coronary cusp of the aortic valve is an anatomy-specific risk in perimembranous defects. Nickel hypersensitivity reactions (rare) may occur with standard nitinol devices; ceramic-surface alternatives (Lifetech CeraFlex) reduce this risk. Residual shunts are generally small and often close spontaneously within 3–6 months as device endothelialization completes. Vascular access complications (femoral vein thrombosis, hematoma) are uncommon with current low-profile sheath systems. Anesthesia and Bypass Risks: In infants, CPB carries risks of systemic inflammatory response syndrome (SIRS), acute kidney injury (requiring transient peritoneal dialysis in 2–5% of neonatal cases), and transient cognitive effects studied under neurodevelopmental follow-up programs. High-volume centers mitigate these through modified ultrafiltration (MUF), pH-stat blood gas management, and near-infrared spectroscopy (NIRS) monitoring. Long-Term Considerations: Patients require lifelong cardiology surveillance, as late arrhythmias (including complete heart block even years post-repair), progressive aortic regurgitation, and rare patch complications have been described. Infective endocarditis risk, though significantly reduced after successful repair, persists during the first 6 months post-implant and in patients with residual shunts. Neurodevelopmental monitoring is recommended for all patients who underwent open cardiac surgery in infancy, as subtle differences in school-age cognitive and motor performance have been documented in population studies, underscoring the importance of early identification and intervention.
Why GAF Healthcare
GAF Healthcare provides a comprehensive, single-point medical travel management service designed to eliminate logistical friction for international families, covering every stage from initial inquiry to post-discharge remote follow-up. VISA & ENTRY ASSISTANCE — INDIA: GAF Healthcare's dedicated visa facilitation team prepares and submits e-Medical Visa applications (and e-Medical Attendant Visa applications for up to two accompanying caregivers) on behalf of the patient's family, liaising directly with the Indian High Commission or Consulate in the patient's home country. The e-Medical Visa allows multiple entries over 60 days per visit, extendable through the Foreigners Regional Registration Office (FRRO) if the recovery period requires longer stay. GAF provides a formal hospital invitation letter — a mandatory supporting document for the e-Medical Visa — issued on the treating hospital's letterhead within 24–48 hours of case acceptance. VISA & ENTRY ASSISTANCE — UAE: The UAE operates a streamlined medical tourism entry framework. Nationals from over 90 countries receive visa-on-arrival or visa-free entry for 30–90 days. For patients from countries requiring advance visas, GAF Healthcare coordinates the medical visa application through Dubai Health Authority (DHA) or Health Authority Abu Dhabi (HAAD) affiliated channels, including the Dubai Medical Tourism programme. A formal treatment confirmation letter from the UAE hospital is provided for visa support. UAE medical visa holders are entitled to accompany one attendant under companion visa provisions. AIRPORT TRANSFERS & IN-COUNTRY MOBILITY: All transfers — arrival airport pickup, hospital admissions transport, inter-facility referral transport, discharge-to-accommodation transfers, and return airport drop-off — are arranged by GAF Healthcare using medically equipped, air-conditioned vehicles staffed by trained medical escorts when the patient's condition warrants it. Wheelchair-accessible and stretcher-compatible vehicles are available on request. DEDICATED MEDICAL INTERPRETERS & PATIENT ADVOCATES: GAF Healthcare assigns a named Patient Relationship Manager (PRM) who speaks the family's preferred language (Arabic, French, Russian, Swahili, Amharic, and other languages supported) and accompanies the family to clinical consultations, consent discussions, ward rounds, and discharge planning meetings. The PRM is available via direct mobile and WhatsApp 24 hours a day, 7 days a week throughout the in-country stay. ACCOMMODATION FOR ATTENDANTS: GAF Healthcare maintains partnerships with serviced apartment complexes and guesthouses within 1–3 km of each partner hospital in India (Hyderabad, Chennai, Mumbai, Delhi, Bangalore) and the UAE (Dubai Healthcare City, Abu Dhabi Medical District). Attendant accommodation options range from budget-friendly guesthouses to fully serviced family apartments with housekeeping, laundry, and in-room kitchenettes — essential for families with young children. Rates are negotiated at below-market prices exclusively for GAF Healthcare patients. FINANCIAL COORDINATION & INSURANCE LIAISON: GAF Healthcare provides detailed, itemized cost estimates before any commitment, enabling families to plan precisely. For patients with international health insurance or reinsurance coverage through government schemes (e.g., Indian CGHS, Gulf state national health coverage), GAF's billing team prepares documentation packages compliant with insurer pre-authorization requirements. Interest-free installment payment arrangements are available for select partner hospitals. POST-DISCHARGE REMOTE CARE: Following return to the home country, GAF Healthcare's telemedicine coordination service facilitates scheduled video consultations between the patient's family and the treating cardiac surgeon or cardiologist at the 1-month, 3-month, and 6-month post-procedure milestones, ensuring continuity of care and prompt escalation of any concerns identified by the home-country physician.
Common questions about Ventricular Septal Defect (VSD) Repair
What is the cost of VSD Repair in India compared to the UAE?
How long do I need to stay in the country before I am fit to fly home after VSD Repair?
What is the success rate of VSD Repair, and what outcomes can I expect for my child?
Related pages
How GAF Healthcare Assists in Choosing the Best Hospital for Ventricular Septal Defect (VSD) Repair in Hyderabad, India
Discover the Top Hospitals for Ventricular Septal Defect (VSD) Repair in Hyderabad, India
This page lists 4 accredited paediatric cardiology hospitals in Hyderabad, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Frequently asked questions about ventricular septal defect (vsd) repair in Hyderabad, India
How many paediatric cardiology hospitals are listed in Hyderabad, India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Are there paediatric cardiology hospitals for this in other India cities?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for ventricular septal defect (vsd) repair in Hyderabad, India.
Contact us to report an inaccuracy on this page.